학술논문
A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs
Document Type
Article
Author
Réa, D.; Mauro, M.J.; Boquimpani, C.; Minami, Y.; Lomaia, E.; Voloshin, S.; Turkina, A.; Kim, D.-W.; Apperley, J.F.; Abdo, A.; Fogliatto, L.M.; Kim, D.D.H.; le Coutre, P.; Saussele, S.; Annunziata, M.; Hughes, T.P.; Chaudhri, N.; Sasaki, K.; Chee, L.; García-Gutiérrez, V.; Cortes, J.E.; Aimone, P.; Allepuz, A.; Quenet, S.; Bédoucha, V.; Hochhaus, A.
Source
In: Blood . (Blood, 25 November 2021, 138(21):2031-2041)
Subject
Language
English
ISSN
15280020
00064971
00064971